Francisco Aya

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 6

Top Topics

Computed Tomography

Tyrosine Kinase

Prognostic Factors

Top Venues

International journal of molecular sciences

This page only lists publications with an associated author ORCID identifier.

Publications

Estefania Serra, Álvaro Abarzua-Araya, Ana Arance, Roberto Martin-Huertas, Francisco Aya, María Lourdes Olondo, Daniel Rizo-Potau, Josep Malvehy, Susana Puig, Cristina Carrera, Sebastian Podlipnik
Predictive and Prognostic Factors in Melanoma Central Nervous System Metastases-A Cohort Study. Cancers 16 (12) (2024)
Estefania Serra, Álvaro Abarzua-Araya, Ana Arance, Roberto Martin-Huertas, Francisco Aya, María Lourdes Olondo, Daniel Rizo-Potau, Josep Malvehy, Susana Puig, Cristina Carrera, Sebastian Podlipnik
Predictive and Prognostic Factors in Melanoma Central Nervous System Metastases-A Cohort Study. Cancers 16 (12) (2024)
Clara Martínez-Vila, Europa Azucena González-Navarro, Cristina Teixidó, Roberto Martin, Francisco Aya, Manel Juan, Ana Arance
Lymphocyte T Subsets and Outcome of Immune Checkpoint Inhibitors in Melanoma Patients: An Oncologist's Perspective on Current Knowledge. International journal of molecular sciences 25 (17) (2024)
Lorena Villa-Crespo, Sebastian Podlipnik, Natalia Anglada, Clara Izquierdo, Priscila Giavedoni, Pablo Iglesias, Mireia Dominguez, Francisco Aya, Ana Arance, Josep Malvehy, Susana Puig Sardà, Cristina Carrera
Timeline of Adverse Events during Immune Checkpoint Inhibitors for Advanced Melanoma and Their Impacts on Survival. Cancers 14 (5) (2022)
Francisco Aya, E Azucena González-Navarro, Clara Martínez, Esther Carcelero, Ana Arance
Safe anti-programmed cell death-1 rechallenge with antibody switching after immune-related adverse events: brief communication. Immunotherapy 13 (9) (2021)
Francisco Aya, Mariana Benegas, Nuria Viñolas, Roxana Reyes, Ivan Vollmer, Ainara Arcocha, Marcelo Sanchez, Noemi Reguart
A Pilot Study to Evaluate Early Predictive Value of Thorax Perfusion-CT in Advanced NSCLC. Cancers 13 (21) (2021)